跳至主要内容
临床试验/CTRI/2022/09/046010
CTRI/2022/09/046010尚未招募3 期

EFFECT OF MRIDHWIKADHI KASHAYA AND PANCHAGANDHA CHOORNAM THALAM IN THE MANAGEMENT OF PRIMARY HYPERTENSION

Sri jayendra saraswathi ayurveda college and hospital1 个研究点 分布在 1 个国家目标入组 40 人开始时间: 2022年5月10日最近更新:

试验速览

阶段
3 期
状态
尚未招募
入组人数
40
试验地点
1
主要终点
Reduction in the blood pressure

研究概览

简要总结

Itis estimated that 17.6% of patient with primary hypertension globally live in india.the increased prevalence of hypertension and pre-hypertension among youngindians is being increasingly reported. there are high prevalence ofhypertension among indian adults, across all age groups. in addition there is apoor awareness, treatment and control among those with hypertension. also inmore than 95% of the cases specific underlying causes of hypertension is notfound. such patient are known to have primary hypertension.

 Primaryhypertension accounts 90-95% of adult cases and 2-10% of them have secondarycause. in contemprory science anti-hypertension drug therapy using thiazide,β-adrenoceptor antagonists, calcium antagonists, vasodilators, angiotensionconverting hormone enzyme inhibitor drugs with or without combinations aregiven to combat hypertension. persistant usage of these drugs will lead to“resistance hypertension†which is followed by serious complications.  thus to combat these hazardous steps, someeffective management are needed.

Hence this study isplanned  to bring out effective managementof primary hypertension with administration of mridhwikadhi kashayam internallyand panchgandha choornam thalam  externally

研究设计

研究类型
Interventional
分配方式
Not Applicable
盲法
Not Applicable

入排标准

年龄范围
25.00 Year(s) 至 55.00 Year(s)(—)
性别
All

入选标准

  • Cases with elevated systolic and diastolic blood pressure with possible complaints of Headache, dizziness , breathlessness, palpitation and insomnia
  • Diagnosed patients of primary hypertension willing to participate and sign the informed consent form will be selected for the study
  • Age between 25-55 4.all genders.

排除标准

  • 1.Coronary artery diseases 2.Congestive heart failure 3.Pulmonary tuberculosis 4.Liver disorders 5.Kidney disorders 6.Spleen disorders 7.Diabetes mellitus & diabetes insipidus 8.Cardiac myopathies 9.Stage 2 hypertension 10.Malignant hypertension and secondary hypertension 11.Pregnant women 12.Patient under anti-hypertensive drugs, drugs- cortico-steroids 13.Patients with hereditary dispositions 14.Other systemic illness 15.Sleshma vikara rogi 16.Cervical pathologies.

结局指标

主要结局

Reduction in the blood pressure

时间窗: 28 Days

and symptoms such as headache, insomnia, dizziness, breathlessness and palpitation.

时间窗: 28 Days

次要结局

  • Reduction in the blood pressure(and symptoms such as headache, insomnia, dizziness, breathlessness and palpitation.)

研究者

申办方类型
Private medical college

研究点 (1)

Loading locations...

相似试验